Mode
Text Size
Log in / Sign up

Meta-analysis finds AI tools show high accuracy for Schistosoma haematobium detection in sub-Saharan Africa

Meta-analysis finds AI tools show high accuracy for Schistosoma haematobium detection in…
Photo by Ben Maffin / Unsplash
Key Takeaway
Consider AI-assisted tools for Schistosoma haematobium screening in endemic areas, but note high heterogeneity limits generalizability.

This is a meta-analysis of 10 studies (15 datasets, 5,564 urine samples) conducted in sub-Saharan Africa. It synthesized the diagnostic accuracy of AI-assisted tools for detecting Schistosoma haematobium infection, compared to microscopy and/or molecular reference standards. The authors reported a pooled sensitivity of 88% (95% CI 83%-91%) and a pooled specificity of 89% (95% CI 83%-93%). The pooled diagnostic odds ratio was 54.00 (95% CI 30.41-95.88), and the SROC curve AUC was 0.94 (95% CI 0.92-0.96), indicating strong discrimination and excellent overall accuracy. The authors acknowledge that heterogeneity across studies was high (I² = 100%), suggesting results varied by the specific AI platform and study context. They note that AI-assisted tools showed promise for detecting infections and could help screen populations in endemic areas, but further validation in field settings and comparison to highly sensitive reference tests is needed. Practice relevance is restrained, as the findings are specific to the included studies and contexts.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BACKGROUND: Urogenital schistosomiasis caused by Schistosoma haematobium remains endemic in sub-Saharan Africa. Diagnosis traditionally relies on urine microscopy to detect parasite eggs; however, its sensitivity declines in low-intensity infections. Artificial intelligence (AI)-assisted image analysis offers a promising approach to automate egg detection and enhance diagnostic accuracy, but its performance compared with standard microscopy is not well established. METHODS: We conducted a systematic review following the PRISMA guidelines and checklist. Studies evaluating AI-assisted detection of S. haematobium compared with microscopy and/or molecular reference standards, published up to August 2025, were identified through searches in PubMed/MEDLINE, HINARI, Epistemonikos, Science Direct, Google Scholar and grey literature sources. Eligible studies were selected based on pre-defined inclusion and exclusion criteria. The quality of included studies was assessed using the QUADAS-2 tool. Heterogeneity among studies was evaluated using the Cochrane Q test and I² statistic. Data was analyzed using STATA version 14.1 and Review Manager version 5.4.1. RESULTS: Ten studies (15 datasets, 5,564 urine samples) conducted in sub-Saharan Africa met the inclusion criteria. AI-assisted tools demonstrated high diagnostic accuracy. The pooled sensitivity was 88% (95%CI 83%-91%) and pooled specificity was 89% (95% CI 83%-93%). The pooled diagnostic odds ratio was 54.00 (95% CI 30.41-95.88), indicating strong discrimination between infected and uninfected cases. The SROC curve yielded an AUC of 0.94 (95% CI 0.92-0.96), reflecting excellent overall accuracy. Heterogeneity across studies was high (I² = 100%), suggesting results varied by the specific AI platform and study context. CONCLUSION: AI-assisted microscopic diagnosis of S. haematobium achieved very good in this meta-analysis. These automated tools, whether smartphone-based or bench-top systems, showed promise for detecting infections and could help screen populations in endemic areas. With further validation in field settings and comparison to highly sensitive reference tests, AI diagnostic technology may become a valuable tool to improve case detection and support schistosomiasis control and elimination efforts.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.